Ambien (zolpidem) is approved for short-term use only, and the FDA recommends reassessing if your insomnia hasn’t improved within 7 to 10 days. There is no FDA-approved timeline for long-term continuous use. In practice, some people take it longer under medical supervision, but the risk of dependence increases the longer you use it.
The 7 to 10 Day Benchmark
The FDA prescribing label is clear: treatment with zolpidem “should be as short as possible because the risk of abuse and dependence increases the longer you are being treated.” If your sleep problems haven’t improved after 7 to 10 days, the label states this may indicate another condition is causing your insomnia, whether that’s anxiety, depression, sleep apnea, or something else entirely.
This doesn’t mean your prescription will always be limited to 10 days. Many doctors prescribe Ambien for weeks or even months when they judge the benefits outweigh the risks. But the official guidance treats anything beyond that initial window as a signal to dig deeper into what’s driving your sleep problems rather than simply continuing the medication.
As-Needed Use vs. Nightly Use
One approach that extends the safe window is taking Ambien only on nights you truly need it rather than every single night. Studies comparing nightly use to intermittent, as-needed use have found comparable effectiveness for both approaches. Most people with chronic insomnia don’t struggle every night, so taking the medication selectively, perhaps three or four nights a week, reduces your total exposure and lowers the risk of building tolerance or dependence.
If your doctor prescribes Ambien for longer than two weeks, as-needed dosing is typically the preferred strategy. This pattern gives your brain regular breaks from the drug and helps you identify which nights you can manage without it.
What Happens With Long-Term Use
The core concern with taking Ambien for months or years is dependence. Your brain adapts to the drug’s presence, meaning you may need higher doses for the same effect (tolerance) and experience withdrawal symptoms if you stop abruptly. The risk climbs with both dose and duration.
The cognitive picture is more nuanced than many people assume. One study of middle-aged and older adults with chronic insomnia found that zolpidem use did not correlate with global cognitive decline, and users actually performed better on attention tasks. However, other research, particularly a large study in Taiwan, has linked high cumulative doses of zolpidem to increased Alzheimer’s risk in elderly populations. The takeaway: occasional use at standard doses carries less cognitive concern than years of heavy use, but the long-term data is still mixed.
Beyond cognition, the FDA has flagged two serious safety issues. The first is next-morning impairment, where the drug remains in your bloodstream long enough to affect alertness the following day, especially at higher doses. The second is complex sleep behaviors: sleepwalking, sleep-driving, preparing food, or making phone calls with no memory of doing so. Both risks exist even with short-term use but compound over time as doses tend to creep upward.
Special Risks for Older Adults
The American Geriatrics Society lists zolpidem and other “Z-drugs” on its Beers Criteria, a widely used list of medications that older adults should avoid. The recommendation is strong, backed by moderate-quality evidence. In older adults, these drugs carry risks similar to benzodiazepines: delirium, falls, fractures, increased emergency room visits, and motor vehicle crashes. At the same time, the actual sleep improvement they provide is minimal, often just a few extra minutes of sleep per night.
For people with dementia, cognitive impairment, or a history of delirium, zolpidem is specifically flagged as a drug to avoid because it can worsen these conditions. If you’re over 65 and currently taking Ambien, it’s worth discussing alternatives with your doctor.
Recommended Dosing by Gender
Women metabolize zolpidem more slowly than men, which means the drug lingers in their systems longer. The FDA now requires lower recommended starting doses for women. For standard immediate-release tablets, women are advised to start at half the dose typically prescribed to men. Men are also encouraged to consider the lower dose. This change was driven by data showing that next-morning blood levels in women were frequently high enough to impair driving.
How to Stop Safely
If you’ve been taking Ambien regularly for more than a few weeks, stopping abruptly is not recommended. Sudden discontinuation can trigger rebound insomnia that’s worse than your original sleep problems, along with anxiety and, in rare cases involving very high doses, seizures or hallucinations. Rebound insomnia typically peaks around the second or third night after stopping and can make sleep difficult until the early morning hours.
Clinical guidelines from the American Academy of Family Physicians recommend a gradual taper: reducing your dose by 25% every two weeks, with medication-free nights introduced toward the end. For people whose current dose doesn’t divide neatly into 25% increments, a 50% reduction with a temporary switch to a different short-acting medication during the final tapering phase is an alternative. The entire process typically takes six to eight weeks, though it varies depending on how long you’ve been taking the drug and at what dose.
During tapering, expect some rough nights. Rebound insomnia is common but temporary. Many people find that their sleep stabilizes within one to two weeks of completing the taper, often better than they expected. Cognitive behavioral therapy for insomnia (CBT-I), which retrains sleep habits without medication, is considered the first-line long-term treatment for chronic insomnia and works well as a bridge during and after tapering.